| Product Code: ETC10600590 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The India human insulin drugs and delivery devices import market experienced a shift in concentration levels from very high in 2023 to moderate in 2024, indicating increased diversification among importing countries. Top exporters such as Australia, USA, South Korea, Germany, and New Zealand played key roles in supplying these products to India. However, the market saw a significant decline in growth rate from 2023 to 2024, with a CAGR of -14.84%. This trend may prompt stakeholders to explore strategies to stimulate market recovery and foster sustainable growth in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Human Insulin Drugs and Delivery Devices Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 India Human Insulin Drugs and Delivery Devices Market - Industry Life Cycle |
3.4 India Human Insulin Drugs and Delivery Devices Market - Porter's Five Forces |
3.5 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Insulin Type, 2021 & 2031F |
3.6 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Delivery Device, 2021 & 2031F |
3.7 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Patient Demographic, 2021 & 2031F |
3.9 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Treatment Goal, 2021 & 2031F |
4 India Human Insulin Drugs and Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in India |
4.2.2 Growing awareness about diabetes management and treatment |
4.2.3 Technological advancements in insulin delivery devices |
4.3 Market Restraints |
4.3.1 High cost associated with insulin drugs and delivery devices |
4.3.2 Limited access to healthcare facilities in rural areas |
4.3.3 Stringent regulatory requirements for drug approval |
5 India Human Insulin Drugs and Delivery Devices Market Trends |
6 India Human Insulin Drugs and Delivery Devices Market, By Types |
6.1 India Human Insulin Drugs and Delivery Devices Market, By Insulin Type |
6.1.1 Overview and Analysis |
6.1.2 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Type, 2021 - 2031F |
6.1.3 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Rapid-Acting Insulin, 2021 - 2031F |
6.1.4 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-Acting Insulin, 2021 - 2031F |
6.1.5 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Pre-mixed Insulin, 2021 - 2031F |
6.1.6 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Glargine, 2021 - 2031F |
6.2 India Human Insulin Drugs and Delivery Devices Market, By Delivery Device |
6.2.1 Overview and Analysis |
6.2.2 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pens, 2021 - 2031F |
6.2.3 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps, 2021 - 2031F |
6.2.4 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Syringes, 2021 - 2031F |
6.2.5 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps/Pens, 2021 - 2031F |
6.3 India Human Insulin Drugs and Delivery Devices Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.3 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.5 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 India Human Insulin Drugs and Delivery Devices Market, By Patient Demographic |
6.4.1 Overview and Analysis |
6.4.2 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.4.3 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.4.4 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Children, Adults, 2021 - 2031F |
6.4.5 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Elderly Population, 2021 - 2031F |
6.5 India Human Insulin Drugs and Delivery Devices Market, By Treatment Goal |
6.5.1 Overview and Analysis |
6.5.2 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Blood Sugar Control, 2021 - 2031F |
6.5.3 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-term Glycemic Control, 2021 - 2031F |
6.5.4 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Immediate Blood Sugar Regulation, 2021 - 2031F |
6.5.5 India Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Overnight Glucose Control, 2021 - 2031F |
7 India Human Insulin Drugs and Delivery Devices Market Import-Export Trade Statistics |
7.1 India Human Insulin Drugs and Delivery Devices Market Export to Major Countries |
7.2 India Human Insulin Drugs and Delivery Devices Market Imports from Major Countries |
8 India Human Insulin Drugs and Delivery Devices Market Key Performance Indicators |
8.1 Number of diabetes diagnoses in India |
8.2 Adoption rate of insulin delivery devices |
8.3 Research and development investment in diabetes treatments |
8.4 Patient satisfaction with insulin products and delivery devices |
8.5 Number of healthcare facilities offering diabetes management services |
9 India Human Insulin Drugs and Delivery Devices Market - Opportunity Assessment |
9.1 India Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Insulin Type, 2021 & 2031F |
9.2 India Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Delivery Device, 2021 & 2031F |
9.3 India Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 India Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Patient Demographic, 2021 & 2031F |
9.5 India Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Treatment Goal, 2021 & 2031F |
10 India Human Insulin Drugs and Delivery Devices Market - Competitive Landscape |
10.1 India Human Insulin Drugs and Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 India Human Insulin Drugs and Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |